1. Newman WP, Friedman DS, Voors AW.
Relation of serum lipoprotein levels and systolic blood
pressure to early atherosclerosis: the Bogalusa Heart Study.
New Engl J Med 1986, 314: 138-144.
2. Muuronen A, Kaste M, Nikkila EA,
Tolppanen EM. Mortality from ischemic heart disease among
the patients using anticonvulsant drugs: A case control
study. BMJ 1985; 291: 1481-1483.
3. Miller GJ. The epidemiology of plasma
lipoproteins and atherosclerotic disease. In: Miller
NE, Lewis B (eds). Lipoproteins, atherosclerosis and
coronary heart disease. Elsevier, Amsterdam, pp 59-71.
4. Luoma PV. Microsomal enzyme induction
lipoprotein and atherosclerosis. Pharmacol Toxicol 1988; 62:
243-249.
5. Demircioglu S, Soylu A, Diric E.
Carbamazepine and valproic acid: Effects on the serum lipids
and liver functions in children. Pediatr Neurol 2000, 23:
142-146.
6. Zeilthoper S, Doppelbauer A, Tribl G,
Leitha T, Deecke L. Changes in serum lipid pattern during
long term anticonvulsant treatment. Clin Invest 1993; 71:
574-578.
7. Eris JM, Lojo S, Del Rio MC, Novo I.
Effect of long term treatment with antiepileptic drugs on
serum lipid levels in children with epilepsy. Neurology
1995; 45: 1155-1157.
8. Yilmaz E, Dosan Y, Gurgoze MK, Gungor
S. Serum lipid changes during anticonvulsive treatment in
epileptic children. Acta Neurol Belg 2001; 101: 217-220.
9. Nikolaos T, Stylianos G, Chryssoula N,
Irini P, Christos M, Dimitrios T, et al. The effect
of long-term antiepileptic treatment on serum cholesterol (TC,
HDL, LDL) and triglyceride levels in adult epileptic
patients on monotherepy. Med Sci Monit 2004; 10: MT50- MT52.
10. Franzoni E, Govoni M, D’Addato S,
Gualandi S, Sangiorgi Z, Descovich GC, et al. Total
cholesterol, high density lipoprotein cholesterol and
Triglycerides in children receiving antiepileptic drugs.
Epilepsia 1992; 33: 932-935.
11. Eiris JM, Rodriguez IN, Rio MD,
Mesegaer P, Rio MC, Gago MC. The effects on lipid and
apolipoprotein serum levels of long-term carbamazepine,
valproic acid and pheno-barbital therapy in children with
epilepsy. Epilepsy Research 2000: 41: 1-7.
12. Havel RJ, Kane JP. Structure and
metabolism of plasma lipoproteins. In: Secriver CR, Beaudet
AL, Sly WS, Valle D (eds). The Metabolic and Molecular Basis
of Inherited Disease, 7th edn, vol II. New York,
McGraw-Hill, 1995; pp 1841-1851.
13. Dada G, Caksen H, Icagasioglu D.
Effect of long term carbamazepine therepy on serum lipids,
vitamin B12 and folic acid level in children. J Pediatr
Endocrinol Metab 2003; 16: 193-196.
14. Bramswig S, Sudhop T, Luers C, Von
Bergman K, Berthhold HK. Lipoprotein A concentration
increases during treatment with carbamaze-pine. Epilepsia
2003; 44: 457-460.
15. American Academy of Pediatrics,
Committee on Nutrition. Statement on cholesterol. Pediatrics
1992; 90: 469-473.
16. Tjellesen L, Christiansen C. Serum vitamin D
metabolites in epileptic patients treated with two different
anticonvulsants. Acta Neurol Scand 1982, 66: 335-341.